scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1574-695X.2007.00337.X |
P698 | PubMed publication ID | 17919298 |
P50 | author | Sandra Torriani | Q46593992 |
Yolanda Sanz | Q60388687 | ||
P2093 | author name string | Franco Dellaglio | |
Miguel Calabuig | |||
Marta Marzotto | |||
Ester Sánchez | |||
P433 | issue | 3 | |
P921 | main subject | feces | Q496 |
bacterial community | Q129982151 | ||
electrophoresis | Q185098 | ||
P304 | page(s) | 562-568 | |
P577 | publication date | 2007-10-04 | |
P1433 | published in | FEMS Immunology and Medical Microbiology | Q15767550 |
P1476 | title | Differences in faecal bacterial communities in coeliac and healthy children as detected by PCR and denaturing gradient gel electrophoresis | |
P478 | volume | 51 |
Q33610793 | A distinctive 'microbial signature' in celiac pediatric patients |
Q38199096 | A metabolomic perspective on coeliac disease. |
Q38839739 | A microbiota-centric view of diseases of the upper gastrointestinal tract |
Q41312547 | An In Vitro Fermentation Study on the Effects of Gluten FriendlyTM Bread on Microbiota and Short Chain Fatty Acids of Fecal Samples from Healthy and Celiac Subjects |
Q33416742 | Application of sequence-dependent electrophoresis fingerprinting in exploring biodiversity and population dynamics of human intestinal microbiota: what can be revealed? |
Q35056256 | Bifidobacteria: their impact on gut microbiota composition and their applications as probiotics in infants |
Q40030609 | Bifidobacterium strains suppress in vitro the pro-inflammatory milieu triggered by the large intestinal microbiota of coeliac patients. |
Q39954551 | Can Colonoscopy Aspirates be a Substitute for Fecal Samples in Analyses of the Intestinal Microbiota? |
Q90614073 | Celiac Disease and the Microbiome |
Q33981675 | Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease |
Q34200219 | Characterization of the active microbiotas associated with honey bees reveals healthier and broader communities when colonies are genetically diverse |
Q35882924 | Characterizing the Intestinal Microbiome in Infantile Colic: Findings Based on an Integrative Review of the Literature |
Q54334422 | Commensal and probiotic bacteria influence intestinal barrier function and susceptibility to colitis in Nod1-/-; Nod2-/- mice. |
Q44975535 | Composition and diversity of the duodenal mucosa-associated microbiome in children with untreated coeliac disease |
Q59137735 | Cross-Talk Between Gluten, Intestinal Microbiota and Intestinal Mucosa in Celiac Disease: Recent Advances and Basis of Autoimmunity |
Q36250322 | Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease |
Q36046182 | Differences in the Biodiversity of the Fecal Microbiota of Infants With Rotaviral Diarrhea and Healthy Infants |
Q33986375 | Differences of small intestinal bacteria populations in adults and children with/without celiac disease: effect of age, gluten diet, and disease. |
Q33431774 | Different fecal microbiotas and volatile organic compounds in treated and untreated children with celiac disease |
Q36924911 | Diversity of the gut microbiota and eczema in early life |
Q35443254 | Does the microbiota play a role in the pathogenesis of autoimmune diseases? |
Q34039831 | Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization |
Q37028512 | Duodenal microbiota composition and mucosal homeostasis in pediatric celiac disease |
Q34802876 | Duodenal-mucosal bacteria associated with celiac disease in children. |
Q38685400 | Gut Microbiota and Celiac Disease |
Q35196152 | High-protein diet modifies colonic microbiota and luminal environment but not colonocyte metabolism in the rat model: the increased luminal bulk connection. |
Q33489534 | Host responses to intestinal microbial antigens in gluten-sensitive mice |
Q46817256 | Identification and characterization of intestinal lactobacilli strains capable of degrading immunotoxic peptides present in gluten. |
Q26825626 | Identification and significance of Weissella species infections |
Q33395121 | Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease |
Q36134568 | Impact of Gluten-Friendly Bread on the Metabolism and Function of In Vitro Gut Microbiota in Healthy Human and Coeliac Subjects |
Q35136415 | Influence of intrapartum antibiotic prophylaxis against group B Streptococcus on the early newborn gut composition and evaluation of the anti-Streptococcus activity of Bifidobacterium strains |
Q33534036 | Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children |
Q47104884 | Intestinal epithelium, intraepithelial lymphocytes and the gut microbiota - Key players in the pathogenesis of celiac disease. |
Q35198926 | Intestinal microbiota and probiotics in celiac disease |
Q27001712 | Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis |
Q24628739 | Intestinal microbiota in human health and disease: the impact of probiotics |
Q58610297 | Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels |
Q35979849 | Metagenomics Reveals Dysbiosis and a Potentially Pathogenic N. flavescens Strain in Duodenum of Adult Celiac Patients |
Q37813012 | Microbiota restoration: natural and supplemented recovery of human microbial communities |
Q38164068 | Non-nutritional effects of food: an underutilized and understudied therapeutic tool in chronic gastrointestinal diseases |
Q35657347 | Novel players in coeliac disease pathogenesis: role of the gut microbiota |
Q37633863 | Oral biofilms: emerging concepts in microbial ecology |
Q34307239 | Pathophysiology of celiac disease |
Q37150557 | Probiotics and the Microbiome in Celiac Disease: A Randomised Controlled Trial. |
Q60949642 | Probiotics in Celiac Disease |
Q27027791 | Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology |
Q34202899 | Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants |
Q24756993 | Salivary microbiota and metabolome associated with celiac disease |
Q33640334 | Significantly higher faecal counts of the yeasts candida and saccharomyces identified in people with coeliac disease |
Q35935437 | Study of duodenal bacterial communities by 16S rRNA gene analysis in adults with active celiac disease vs non-celiac disease controls. |
Q27012714 | Systematic review: early infant feeding and the prevention of coeliac disease |
Q57030425 | The Effect of Gluten-Free Diet on Health and the Gut Microbiota Cannot Be Extrapolated from One Population to Others |
Q50033816 | The Effect of Oligofructose-Enriched Inulin on Faecal Bacterial Counts and Microbiota-Associated Characteristics in Celiac Disease Children Following a Gluten-Free Diet: Results of a Randomized, Placebo-Controlled Trial |
Q35184300 | The genus Weissella: taxonomy, ecology and biotechnological potential |
Q37283086 | Triggers and drivers of autoimmunity: lessons from coeliac disease |
Q37538105 | US perspective on gluten-related diseases |
Q27002380 | Upper gastrointestinal microbiota and digestive diseases |
Search more.